All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...

The kidney failure rate was 10.5 vs 9.2 per 100 person-years, respectively. Subgroup analyses showed that patients with stage 3 CKD had a significant 39% increased risk of ESKD, but patients with ...